Navigation Links
OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
Date:6/26/2012

r this year."

About OMS-I100

A total of up to 25 patients with Stage III or IV cutaneous and in-transit metastatic melanoma will be enrolled in this Phase II, single-arm, open-label, and multi-center study. The trial is designed to assess local and distant objective response following treatment of cutaneous melanoma lesions with DNA IL-12 and electroporation with a primary endpoint of 24 weeks. One treatment cycle will consist of three treatments applied to up to four lesions on days one, five and eight with a maximum dose of 1.5 mg DNA IL-12 per treatment cycle. At 12 months, patients will be moved to the follow-up phase of the study and will be followed for up to five years for safety.

About Melanoma

The incidence of many common cancers is falling, but the incidence of melanoma continues to rise at a rate faster than that of any of the seven most common cancers. Between 1992 and 2004, melanoma incidence increased 45 percent, or 3.1 percent annually. An estimated 68,000 new cases of melanoma were diagnosed in the U.S. in 2010 — with nearly 8,700 resulting in death. Approximately 75 percent of skin cancer deaths are from melanoma. In 2004, the most recent figures available, the total direct medical cost associated with the treatment of skin cancer in the U.S. was $1.5 billion. Currently there are few treatment options for metastatic melanoma because of  the aggressive nature of the disease. Current treatment approaches are associated with high morbidity and only marginal improvements in overall survival.

About OncoSec Medical Inc.

OncoSec Medical Incorporated is a biopharmaceutical company developing advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers and metastatic disease. OMS ElectroOncology therapies address an unmet medical need and represent a potential solution for less invasive and less expensive therapies that are able to minimize detrimental effec
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
4. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
5. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
6. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
7. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
8. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
9. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
10. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  Unilife Corporation ("Unilife" ... announced today that it intends to release its financial ... ended June 30, 2014 after market trading ends on ... scheduled a conference call for 4:30 p.m. U.S. EDT ... at 6:30 a.m. AEST), to review the Company,s financial results, ...
(Date:8/29/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... that results in demyelination, axonal transection, and neurodegeneration. The ... by the immune system, which targets neurons within the ... disease in which the damage of the myelin sheath ...
(Date:8/29/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the CL King 12 ... September 9, 2014 at 12:30 p.m. ET. The conference ... in New York City . ...
Breaking Medicine Technology:Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... 24 Sunridge International (OTC Bulletin Board: SNDZ ... month to have meetings with key brokers and funds.  The ... our company,s technology, and to facilitate funding for Sunridge to ... is a good time for this project," states G. Richard ...
... Corporation (Nasdaq: CLSN ), a leading ... U.S. Food and Drug Administration (FDA) has designated ... in combination with radiofrequency ablation (RFA), as a ... liposomal encapsulation of doxorubicin, is currently being evaluated ...
Cached Medicine Technology:Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer 2Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer 3Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer 4
(Date:8/29/2014)... USA (PRWEB) August 29, 2014 As reported ... Is Help (8/15), the process of admitting that you ... a struggle. The article acknowledges and highlights the fact that ... problem, you may be very overwhelmed by all of the ... is nearly impossible to sift through, it is still possible ...
(Date:8/29/2014)... Market Research Report on Global and ... and in-depth market survey on Global and Chinese ... basic information of Glass microfiber including its classification, ... global and China’s top manufacturers of Glass microfiber ... market share etc. , The report further analyzes ...
(Date:8/29/2014)... A recent article discusses the creation ... clothing store for men with gynecomastia, or male breasts, to ... their problem. Board-certified plastic surgeon Dr. Chasan is familiar with ... people only associate male breasts with men who are excessively ... of all ages, often starting in adolescence. Men with the ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 Pursuing ... is set to unveil a stunning new design ... to company figures, the highly notable surrogacy platform has ... January. With over 13,000 visitors a month, the FindSurrogateMother.com ... mothers working toward one common goal — the precious ...
(Date:8/29/2014)... report released yesterday by the Mental Health Commission ... health training and education that police personnel receive. ... issue for Canada,s police community, and today,s report ... enforcement and people with mental illnesses," says Queen,s ... an interest in the area of police psychology. ...
Breaking Medicine News(10 mins):Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Report advocates improved police training 2
... ... Michael Steele join Tea Party Support ( http://teapartysupport.com ) and the ... do whatever is necessary, including the use of any parliamentary device ... its tracks. ,Rush Limbaugh questioned Senate Minority Leader McConnell’s strategy ...
... , SAN DIEGO, Dec. 11 ... of post-secondary education services focused on providing higher access to ... graduate school specializing in psychology programs at the master,s and ... in Career Management and Counseling. , This specialization responds ...
... NEW YORK, Dec. 11 WebMD Health Corp. (Nasdaq: ... offer to purchase up to 5,700,000 shares of its common ... at 5:00 p.m., New York City time on December 10, ... Transfer & Trust Company, the Depositary for the tender offer, ...
... December 11 2009 (Portland, Ore.) More than 10 ... at risk for developing diabetes during pregnancy, according to a ... in the December issue of the Ethnicity and Disease ... women,s gestational diabetes risk is one-third higher than averageand more ...
... , ... Board legally recovers the books and records of U.S. Shanghai Chemical Corporation from Chinese Principals! ... (PRWEB) December 11, 2009 ... Axxexs Capital, Inc. was acquired by a Chinese chemical company in a reverse merger. Principals ...
... ... ... do not believe that they know much about depression , but are highly aware of ... National Alliance on Mental Illness (NAMI)., , ,See full survey results at http://www.nami.org/depression , ...
Cached Medicine News:Health News:Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible 2Health News:Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible 3Health News:Bridgepoint Education's University of the Rockies Introduces New Master of Arts Specialization in Career Management and Counseling 2Health News:WebMD Health Corp. Announces Preliminary Results of Its Tender Offer 2Health News:WebMD Health Corp. Announces Preliminary Results of Its Tender Offer 3Health News:Chinese-American and Korean-American women at highest risk for diabetes in pregnancy 2Health News:Chinese-American and Korean-American women at highest risk for diabetes in pregnancy 3Health News:New Board Gains Control of U.S. Shanghai Chemical Corporation 2Health News:Depression Survey: Implications for Diverse Communities 2Health News:Depression Survey: Implications for Diverse Communities 3
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
Oval solid 16 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Cross action serrated handle with polished finish....
Oval solid 15 mm wide lower plate. Open upper plate with inside dimensions 11 mm x 8 mm. Serrated handle with locking thumb screw and polished finish....
Slender 4.5 mm long rounded platform. Serrated handle with polished finish....
Medicine Products: